Literature DB >> 11548881

Activation of mitogen-activated protein kinases in the non-ischemic myocardium of an acute myocardial infarction in rats.

K Yoshida1, M Yoshiyama, T Omura, Y Nakamura, S Kim, K Takeuchi, H Iwao, J Yoshikawa.   

Abstract

As one of the signal transduction pathways related to myocardial remodeling, mitogen-activated protein kinases (MAPKs) possibly play an important role in ischemic heart disease, but it is still unknown whether myocardial MAPKs are activated in the non-ischemic region of an acute myocardial infarction (AMI). Therefore, the present study investigated the myocardial activity of extracellular signal-regulated kinases (ERKs), c-Jun NH2 terminal kinases (JNKs) and p38MAPK during the acute phase of an infarction of the rat heart, and measured the geometrical ventricular changes by echocardiography. All MAPKs were significantly activated in the ischemic myocardium (IM), non-ischemic septal wall (SW), and right ventricular wall (RV). Furthermore, the activation patterns of MAPKs differed in each region. The activation of p44ERK, JNKs and p38MAPK in the IM occurred rapidly after myocardial ischemia, followed by those in the SW and RV. The activator protein-1 DNA binding activities of the IM, SW and RV increased significantly at I day after coronary ligation. Echocardiography showed increased SW motion and RV dilatation. In conclusion, this is the first in vivo evidence that myocardial MAPKs are activated in the non-ischemic region of an AMI. Echocardiographic results suggest that acceleration of workload and/or stretch may partially induce the activation of MAPKs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11548881     DOI: 10.1253/jcj.65.808

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  8 in total

1.  Activation of mitogen activated protein kinases in post-infarcted patients.

Authors:  Reza Akbarzadeh Najar; Sayyed Mohammad Hossein Ghaderian; Akram Sadat Tabatabaei Panah
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

Review 2.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

3.  Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure.

Authors:  Weihua Zhang; Vijayan Elimban; Mohinder S Nijjar; Suresh K Gupta; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2003

4.  β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.

Authors:  Laurel A Grisanti; Christopher J Traynham; Ashley A Repas; Erhe Gao; Walter J Koch; Douglas G Tilley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

Review 5.  MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.

Authors:  Anthony J Muslin
Journal:  Clin Sci (Lond)       Date:  2008-10       Impact factor: 6.124

6.  LncRNA XIST promotes myocardial infarction by regulating FOS through targeting miR-101a-3p.

Authors:  Bin Lin; Jing Xu; Feng Wang; Jiaxiang Wang; Hui Zhao; Deguang Feng
Journal:  Aging (Albany NY)       Date:  2020-04-21       Impact factor: 5.682

Review 7.  The impact of thyroid hormone dysfunction on ischemic heart disease.

Authors:  Madalena von Hafe; João Sergio Neves; Catarina Vale; Marta Borges-Canha; Adelino Leite-Moreira
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

8.  Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function.

Authors:  Chuang Sun; Guangwei Zeng; Tingting Wang; He Ren; Huixian An; Cheng Lian; Jing Liu; Li Guo; Wei Li
Journal:  Front Cell Dev Biol       Date:  2021-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.